Prenetics Global Stock (NASDAQ:PRE)
Previous Close
$14.81
52W Range
$3.10 - $15.45
50D Avg
$9.75
200D Avg
$7.00
Market Cap
$186.07M
Avg Vol (3M)
$78.28K
Beta
0.33
Div Yield
-
PRE Company Profile
Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.